If you liked this article you might like

Takeover Chatter Around Clovis May Be Overdone
New Setback for Sanofi's Lantus Increases Need for M&A
5 Dividend Stocks That Want to Pay You More Money
Sanofi Fighting a Losing Battle, Sues Merck for Alleged Patent Infrigement